Lucid Diagnostics Inc. (LUCD:NASDAQ) closed at $0.333 on October 21, 2026, down 5.26% on the day. The stock trades 79.5% below its 52-week high of $1.63 and 10.0% above its 52-week low of $0.303. Over the past year, it lost 72.7%. Lucid Diagnostics Inc. is part of the Health Care sector.
In 252 trading sessions since October 21, 2025, LUCD closed higher on 102 days (40%). Its best day was July 15, 2026 (+15.00%) and its worst was October 19, 2026 (-21.05%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 1 time.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.
Find more stocks like LUCD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.